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Malaria remains an overwhelming problem in the tropical developing countries, with 300 to 500 million new cases and about
a million deaths per year (Mishra et al., 2003). Malaria is a potentially life-threatening disease in the tropics. Jaundice is one
o ft h es e v e r em a n i f e s t a t i o n so ffalciparum malaria. Its incidence (Mishra et al., 2003). varies between 10 and 45% in diﬀerent
reports and is seen more in adults than in children. Jaundice may vary from mild to very severe. However, clinical signs of hepatic
encephalopathy (such as liver ﬂaps) are never seen unless there is presence of concomitant viral hepatitis (WHO, 2000). Our case
is a 6-year-old female child presented with fever, jaundice, and anasarca. Peripheral smear showed trophozoites and schizonts of
Plasmodium (P.) vivaxand trophozoites and gametocytes of P. falciparum. Viral markers for hepatitis were negative. She developed
fulminant hepatic failure and expired after 26 hours of admission.
1.Background
Malaria remains a major problem in many parts of the
world. Approximately 500 million people are aﬀected annu-
ally, and approximately 3 million, mostly children, die
of falciparum malaria each year [1, 2]. According to the
World Health Organization’s criteria, the recognition of
one or more of the following clinical features should raise
the suspicion of severe malaria: cerebral malaria (coma),
severe anemia (haemoglobin <5g/dL), renal failure (serum
creatinine >3mg/dL), pulmonary oedema, hypoglycaemia
(glucose <40mg/dL), shock, disseminated intravascular
coagulation, repeated generalized convulsions, acidosis (pH
<7.25), macroscopic haemoglobinuria, hyperparasitaemia
(>5 percent of the erythrocytes infested by parasites), or
jaundice (bilirubin >3mg/dL). A number of patients with
malaria develop severe manifestations, and these patients
require urgent and intensive care. In patients with severe
malarial infestation, the incidence of jaundice is reported
to be 2.58% only [3]. Jaundice in severe P. falciparum
malariaismultifactorial(intravascularhaemolysisofinfested
RBCs/normal RBCs, possibly micro-angiopathic haemol-
ysis associated with DIC, hepatic dysfunction, associated
haemoglobinopathies (not uncommon in malaria-prone
areas), drug-induced haemolysis, and G6PD deﬁciency).
Hepatic dysfunction in malaria has been known for many
years, but hepatic encephalopathy is unusual. According
to the World Health Organization (WHO), apart from
jaundice, signs of hepatic dysfunction are unusual. Jaundice
has been found to be more common in falciparum as
compared to vivax malaria. Hazra et al. found an association
of jaundice in 40% and 9.09% of cases with P. falciparum
and P. vivax, respectively, from Calcutta [4]. Echeverri et al.
in a study of vivax malaria from Colombia have reported an
incidence of jaundice in 15% [5]. Seth et al. found jaundice
in 7.7% of cases of falciparum malaria while they did not
ﬁnd jaundice in vivax malaria [6]. There has not been a
single case report of fulminant hepatic failure due to mixed
malarial infection in children. Jaundice in children infected
with malarial parasite is reported but its incidence is less
compared to adults. According to the WHO, clinical signs
of liver failure such as asterixis are almost never seen unless
thereisconcomitantviralhepatitis.Fulminanthepaticfailure
(FHF), deﬁned as the onset of encephalopathy within 8
weeks of the ﬁrst symptom of hepatic injury, is commonly
due to viral hepatitis or drug use. Infectious diseases such
as sepsis or typhoid fever may present rarely with FHF.
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without altered consciousness, is more common in adults
than children and clinically may resemble acute liver failure.
Our case presented with fulminant hepatic failure due to
mixedmalarialinfection,andconcomitantviralhepatitiswas
ruled out.
2. Case Presentation
Six-year-old female child, ﬁrst product of nonconsan-
guineous marriage resident of New Delhi, presented with
fever for four days, yellowish discoloration of eyes, and urine
for two days, progressive swelling of whole body starting
from feet for one day. Fever was moderate to high grade,
intermittent in type associated with chills and rigor subsided
with medication and profuse sweating. She was having high
coloured urine for two days. Progressive swelling of whole
body for last one day starting from feet then involved the
whole body. Stools were normal in colour. There was no
history of black coloured stools, vomiting, bleeding from
any site, and any change in conscious level, jaundice in
the past, any history of blood transfusion, and intravenous
medication in the past or any history of drug intake. There
was no history suggestive of respiratory tract infections, skin
infection,decreasedmicturition,andreddishcolouredurine.
There was no signiﬁcant past, antenatal, perinatal, or family
history. The child was fully immunized and was receiving
adequate calories and proteins for her age.
On examination, the child was conscious, cooperative,
and orientated. At admission her pulse was 78 per minute,
respiratoryrate26perminute,andbloodpressure98/68mm
of mercury. There were severe pallor, and icterus. Lymph
nodes were not palpable. On abdominal examination liver
was palpable 4cms below costal margin with span of
10cm the spleen was palpable 1cms below costal margin.
Her respiratory, cardiovascular (CVS), and central nervous
system (CNS) examination was unremarkable.
On investigation haemoglobin was 4.9g/dL, total leu-
cocyte count 10.6 × 103 perµL with polymorphs 54%,
lymphocytes 42%, monocyte 4%, platelet count 11×103
perµL and erythrocyte sedimentation rate 8mm/1st hour by
Westergren method. Blood sugar was 84mg/dL. Total serum
bilirubin was 27.5mg/dL, indirect fraction of 18mg/dL.
SGOT was 495 and SGPT 210. Serum total protein was
2.8gram (gm) and albumin 1gm per 100mL of blood.
Blood urea nitrogen was 189mg/dL, creatinine 0.6mg/dL,
sodium 136meq/L, potassium 4.1meq/L. Prothrombin time
was 17.3/12 with INR of 1.44. Viral markers (HBsAg, IgM
hepatitis C, A and E) were negative. Chest X-ray was normal
and ultrasonography abdomen showed hepatosplenomegaly.
On peripheral smear trophozoites and schizonts of P. vivax
and trophozoites and gametocytes of P.falciparumwereseen.
Rapid malarial antigen test was positive. Arterial blood gas
analysisshowedpH7.45,partialpressure(PP)ofoxygen104,
PPofcarbondioxide45,andstandardbicarbonate28meq/L.
Urine routine and microscopy were normal. She was given
injection of Artesunate 2.4gm per kilogram body weight,
along with cefotaxime and vitamin K. She received fresh
frozenplasma,packedredcell,plateletsalongwithinotropes.
Within ﬁve hours of admission she developed profuse
upper gastrointestinal bleeding, along with deterioration of
consciousness. She went into shock, then cardiorespiratory
arrest from which she could not be revived.
3. Discussion
Malaria is a major health problem in many of the developing
and tropical countries. Although rare, severe malaria must
be distinguished from viral FHF. This can have profound
implications for the line of treatment and ultimate patient
outcome. The liver is the ﬁrst organ to be aﬀected in a case of
P. falciparum malaria. After the initial stage (preerythrocyte
schizogony), merozoites are released into the blood stream.
They do not have exoerythrocytic schizogony. But in the
patients of severe malaria, the liver may be involved to
diﬀerent extents. In patients with severe malarial infection,
the incidence of jaundice is reported to be 2.58% only [3].
Presence of jaundice in falciparum malaria indicates a more
severe illness with higher incidence of complications.
Causes of Jaundice in Malaria
Direct causes: malarial hepatitis, intravascular hemo-
lysis of parasitized RBC, and septicemic hepatitis.
Indirect causes: microangiopathic hemolysis associ-
ated with DIC, G6PD-related hemolysis, and anti-
malarial-drug induction.
Unrelated causes: coexisting acute viral hepatitis.
Underlying Chronic Hepatitis. Hyperbilirubinaemia is most-
ly of unconjugated type. Often jaundice is mild, and total
serum bilirubin is below 5mg/dL, but at times bilirubin rises
beyond 50 mg/dL. Enzymes are usually raised (within 3 to 8
times); alanine transaminase (ALT) never reaches to the level
of viral hepatitis. 5  nucleotidases and GGT concentrations
may be moderately elevated. Hypoalbuminaemia is also seen
in these patients. Prothrombin time may be moderately
prolonged. The literature on the hepatic involvement in
malaria has largely shown severe infection with P. falciparum
infection. There have been occasional reports of mixed
infection with P. vivax [7] and hepatitis E [8] along with P.
falciparum, resulting in malarial hepatitis. The management
of malarial hepatitis is not diﬀerent from the management of
severe malarial infection. In endemic areas, it is important
to have a high degree of suspicion of severe infection
with malarial parasite presenting as acute febrile illness
with hepatic dysfunction. The other conditions prevalent
in tropical countries like acute viral infections leading to
hepatitis, enteric fever and leptospirosis should be ﬁgured in
the diﬀerential diagnosis. Since the clinical presentation may
not diﬀer much, laboratory help may be needed to establish
the etiology of malarial hepatitis. Routine, single peripheral
smear examination may not be suﬃcient, so repeated smears
are required to pick up the diagnosis. Treatment of severe
malaria is artesunate or quinine intravenously till the child
becomes conscious thereafter given orally for a total of seven
days.Case Reports in Pediatrics 3
LearningPoints/Take-Home Message
(i) Jaundice is one of the common severe manifestations
of falciparum malaria.
(ii) Altered consciousness in malarial hepatitis, although
uncommon, may make the distinction between
malarial hepatitis and viral FHF diﬃcult.
(iii) Failure to recognize this uncommon presentation
often leads to delayed diagnosis, resulting in poor
outcome.
(iv) Severe malaria due to P. falciparum may masquerade
as FHF. Simple clinical and laboratory parameters
can easily distinguish severe malaria from FHF.
(v) Early diagnosis of malarial FHF has profound impli-
cationsbecausethecornerstoneoftherapyisquinine,
whereas liver transplantation may be required for
FHF in selected patients.
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